Biopolymers can be derived from biological sources, including protein blends with plasticizers, starch, enzymatic synthesis, microorganisms, and algae. They are classified into polynucleotides, polysaccharides, and polypeptides, including polyhydroxyalkanoates, polylactic acid, and thermoplastic starch. Blending polymers with plasticizers and nanoparticles enhances their mechanical, thermal, and barrier properties. Biopolymers have various applications, such as in packaging, textiles, medical devices, cosmetics, agriculture, food products, emulsifiers, construction additives, bioplastics, and biofuels. Some of the advantages of biopolymers include their biodegradability, use of renewable resources, and reduced environmental impact. Nevertheless, certain disadvantages persist, such as high production costs, inadequate waste management systems, material quality loss during recycling, and the limited availability of raw materials. In this context, castor oil has emerged as a promising raw material for biopolymer production, with notable applications in coatings and sealants, and, consequently, bioplastics have become a sustainable and feasible alternative to conventional plastics that aligns with the principles of the circular economy. Moreover, new biopolymers are constantly being developed, and innovative applications are increasingly being explored across industries. The aim of the present review is to analyze the potential of biopolymers as sustainable alternatives to conventional plastics by evaluating their sources, production methods, advantages, limitations, and applications.
Hernández-Hernández et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: